Literature DB >> 7755781

Severe, disseminated, life threatening herpes zoster infection in a patient with rheumatoid arthritis treated with methotrexate.

D W Ching1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7755781      PMCID： PMC1005543          DOI： 10.1136/ard.54.2.155-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Herpes zoster infection in a patient on methotrexate given prednisone to prevent post-herpetic neuralgia.

Authors:  D J Anderson; E N Janoff
Journal:  Ann Intern Med       Date:  1987-11       Impact factor: 25.391

2.  Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate.

Authors:  M A Antonelli; L W Moreland; J E Brick
Journal:  Am J Med       Date:  1991-03       Impact factor: 4.965

3.  Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate.

Authors:  M J van der Veen; A van der Heide; A A Kruize; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

Review 4.  Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature.

Authors:  G D Groff; K N Shenberger; W S Wilke; T H Taylor
Journal:  Semin Arthritis Rheum       Date:  1983-05       Impact factor: 5.532
  4 in total
  1 in total

Review 1.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.